A new study from the University of Texas Medical Branch at Galveston department of Obstetrics and Gynecology has found that although the physicians' white coat is one of the most iconic symbols of the trade, whether or not they wear it, doesn't impact patients' satisfaction. The findings are available in the American Journal of Perinatology.
Past studies have shown that a physician's attire affects patients' trust and confidence in them. Patient satisfaction and quality of communication between patient and physician are linked with better patient care and outcomes.
However, coats worn throughout a day filled with treating patients - some of whom have contagious illnesses - has been shown to carry infectious agents that can be spread around.
The researchers conducted the study to find out if or how the white coat affects physician-patient communication and satisfaction among new mothers in the postpartum unit at the hospital.
All of the women were randomly assigned to teams of rounding physicians who either wore a white coat or not but beyond this, their care was the same. Shortly before discharge from the hospital, the patients completed a modified Hospital Consumer Assessment of Healthcare Providers and Systems survey. The survey is the only national, standardized survey used to assess patient satisfaction.
"Our study showed that not wearing a white coat by the physicians team, didn't impact the communication between patients and physicians nor patients' satisfaction," said Dr. Mauricio La Rosa, principal investigator of the study. "Actually, 40 percent of the patients couldn't remember if their physicians were wearing white coats or not."
In a prior study that was not conducted at UTMB, 18 percent of the physicians' white coats were colonized with antibiotic-resistant Staphylococcus aureus.
Twenty five percent of all hospital admission in the U.S. are related to pregnancy, so any intervention that improves pregnant or postpartum women's satisfaction may have a great impact on health care. Moreover, healthcare professionals must determine the benefits of any interventions whether old or new before widespread utilizations.
Other authors include Nicholas Spencer, Mahmoud Abdelwahab, Gabriela Zambrano, Fawzi Saoud, Katherine Jelliffe, Gayle Olson, Mary Munn, George Saade and Maged Costantine.
Source: University of Texas Medical Branch at Galveston
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.